Picture of Bruno Fonteyn

Bruno Fonteyn

Senior Associate
Lawyer

CMS DeBacker
Chaussée de La Hulpe 178
1170 Brussels
Belgium
Languages French, Dutch, English

Before joining CMS De Backer’s Public Law department in October 2008, Bruno worked for five years as legal counsel for the National Council of the Order of Physicians.

He specialises in Health law, including regulatory matters, hospitals, medical equipment, medical experiments, bio banks and other Life Science matters. Furthermore, he acts in the areas of constitutional and administrative law.

Bruno is a member of the Ethical Committee of a University Hospital, where he delivers legal opinions on medical experiments and ethical matters.

more less

Education

  • 2003 - Université Catholique de Louvain, UCL (Law Degree)
  • 2003 - University of Sherbrooke, Canada
  • 2008 - Bar admission (Brussels, Belgium)
more less

Memberships

  • Legal adviser to the National Council of the Order of Physicians (2003-2008)
  • Member of the Ethical Committee of Erasme Hospital - ULB since March 2008
more less

Publications

  •  « Personalized medicine: a major challenge for social security systems », (with P. Slegers), in SCRIP Regulatory Affairs, CUBITT Consulting, 18 June 2014
  • “Distribution & Marketing of Drugs, Jurisdictional comparisons”, (with P. Slegers), European Lawyer Reference, 2013 p. 29
  • « La plate-forme eHealth – Enjeux de santé publique et de sécurité sociale », (with C. Dubois), Journal des Tribunaux, 24 November 2012, n° 6498,  p. 769 à 776
  • «La directive 2011/24/UE relative à l’application des droits des patients en matière de soins de santé transfrontaliers : bien plus qu’une codification» (with P. Slegers), European Journal of Consumer Law, Larcier, n° 1/2012, p. 61-79
  • «Indemnisation des dommages résultant de soins de santé : le Fonds est mort, vive le Fonds !», (with C. Pouppez and P. Slegers), J.T., 14 mai 2011, n° 6437, p. 373 à 380
  • Comments about « Ziekenhuizen, mededingingsrecht en recht op kwaliteitsvolle zorg” (D. Fornaciari, S. Callens et E. Schokkaert), B. Fonteyn, J.T., 2010, p. 707
  • “L’utilisation de matériel corporel humain à des fins scientifiques: commentaires à propos de la loi du 19 décembre 2008”, co-author with P. Slegers, Journal des Tribunaux, 2009, p. 205
  • “Het Elektronisch Medisch Dossier: uit wettelijk en deontologisch standpunt bekeken”, co-author with Prof. Dr. Michel Deneyer en Prof. Dr. Etienne De Groot, De Praktijkjurist XV, Story, Conferentie van de Jonge Balie te Brugge, 2009, p. 1
  • “L’Ordre des médecins et la procédure disciplinaire”,  co-author with D. Holsters, Le droit disciplinaire des Ordres professionnels (under P. Corvilain supervision), Formation Permanente CUP, 2004, vol. 74
more less

Feed

Show only
16/03/2018
March 2018 News­let­ter
17/04/2018
NGOs can ask the Com­mis­sion to re­view its de­cision on ge­net­ic­ally...
The Gen­er­al Court de­cided in its de­cision of 14 March 2018 that non-gov­ern­ment­al or­gan­iz­a­tions (“NGOs”) can ask the Com­mis­sion to re­view its de­cision on au­thor­iz­ing the pla­cing on the mar­ket of ge­net­ic­ally mod­i­fied food and feed.
31/01/2018
Janu­ary 2018 News­let­ter
31/01/2018
New law fur­ther sup­ports cheap­er pre­scrip­tion drugs
Par­lia­ment ad­op­ted a new law on 25 Decem­ber 2017, which has as one of its ob­ject­ives the pro­mo­tion of the pre­scrip­tion of cheap­er drugs. Pre­scrip­tion drugs are clas­si­fied by price: they can be “cheap medi­cines” or “cheapest medi­cines”, based on dif­fer­ent cri­ter­ia.
30/11/2017
Novem­ber 2017 News­let­ter
25/01/2018
European Com­mis­sion as­sesses ad­equacy of Gen­er­al Food Law in food...
In an eval­u­ation of the EU le­gis­lat­ive frame­work for the 2002 Gen­er­al Food Law Reg­u­la­tion (GFLR), the European Com­mis­sion has found that this frame­work ap­pears to ad­dress most cur­rent trends, such as growth, com­pet­it­ive­ness and in­creased glob­al­isa­tion, but.
19/11/2017
Meet the AI team
07/12/2017
New cent­ral plat­form for health­care pro­fes­sion­als’ ad­min­is­trat­ive...
The Bel­gian Fed­er­al Pub­lic Ser­vice  for Health and the Na­tion­al In­sti­tute for Health and Dis­ab­il­ity In­sur­ance (RIZ­IV) are just a few of the or­gan­iz­a­tions that re­quire cer­tain in­form­a­tion from health­care pro­fes­sion­als.
28/06/2017
June 2017 News­let­ter
07/12/2017
New Roy­al De­cree or­gan­izes the su­per­vi­sion of clin­ic­al tri­als
Fol­low­ing the European Reg­u­la­tion on clin­ic­al tri­als on medi­cin­al products for hu­man use, the Bel­gian le­gis­lat­or ad­op­ted a law on 7 May 2017 ap­ply­ing this Reg­u­la­tion in the Bel­gian leg­al land­scape. The im­ple­ment­a­tion of this law now takes ef­fect with the Roy­al.
27/04/2017
April 2017 News­let­ter
01/12/2017
"Whole gen­ome se­quen­cing" com­ing soon to a clin­ic­al prac­tice in Bel­gi­um?
On 19 Oc­to­ber, Bel­gian health Min­is­ter Mag­gie De Block sub­mit­ted to Par­lia­ment her tra­di­tion­al "note de poli­tique générale" on health for the year 2018. As a sign of the times, one of the pro­pos­als is the in­tro­duc­tion of whole gen­ome se­quen­cing ("WGS") in.